GRI GRI Bio: Net earnings per share for the last 12 months

GRI (GRI Bio) - company brandmark

GRI Bio, Inc. (GRI) automates the creation of NKT inhibitors through robotic complexes. The rolling unit profit indicator on the GURU.Markets daily chart reflects a trend where the value of -44.01 determines this level. GRI Bio, Inc. (GRI) is developing modulators for the therapy of lung and liver inflammation, building intellectual capital and a patent portfolio for the future monetization of pharmaceuticals.

GRI GRI Bio Corporation Earnings per share for the last 12 months (02/21/2024 - 11/12/2026)

Analytical breakdowns for GRI Bio, Inc.

- current quotes and average value forecast:
Price Chart GRI Bio, Inc.|GRI - Consensus Target
- company stock capitalization data:
Market Valuation GRI Bio, Inc.|GRI - Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share GRI Bio|GRI - Accounting Capitalization|Market Capitalization to Book Value Ratio gribio.com|GRI - Company Assets
- debt level and financial liquidity data:
Total Debt to Capital GRI Bio, Inc.|GRI - Long-Term Indebtedness to Equity|Short-Term Debt to Equity GRI Bio Corp|GRI - Aggregate Debt Obligations|Debts to Book Capitalization GRI Bio, Inc.|GRI - Long-Term Debt Volume|Company Current Liabilities GRI Bio|Quick Ratio gribio.com
- earnings and multiples data:
GRI - Company Net Income|Projected Future Earnings GRI Bio, Inc.|GRI - Business Payback Period|Future Price to Earnings GRI Bio|GRI - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio GRI Bio, Inc.|GRI - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) GRI Bio|GRI - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months gribio.com|GRI - Earnings per share growth this year|Earnings growth forecast for next year GRI Bio, Inc.
General company analysis:GRI Bio, Inc. (GRI)
Manufactured products of GRI Bio Corp

The investment attractiveness of GRI Bio, Inc. (GRI) depends on the success of early-stage lung therapy developments and the stability of external funding. The EPS TTM metric aggregates net income over the year, dividing it by the total number of shares to determine the income per asset. Analyzing the EPS trend over 12 months allows investors to filter out speculative noise from actual profitability. For a company with high technological risks, this trend reveals the efficiency of capital management. The indicator's dynamics protect the investor from overvaluing the business in the absence of actual financial growth.

Competitors of GRI Bio, Inc.

ARGX - Earnings per share for the last twelve months|biontech.de (BNTX) - Net earnings per share for the last 12 months|ABVX (Abivax Pharma) - Net earnings per share for the last 12 months|ADMA Biologics Inc (ADMA) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Protagonist Therapeutics Inc|Earnings per share for the last 12 months IMVT (Immunovant Therapeutics)|Net earnings per share (EPS TTM) KNSA|GRFS - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) ADPT (Adaptive Biotechnologies Corporation)|Net earnings per share for the trailing year Celldex Therapeutics Inc|AUPH - Earnings per share for the last twelve months|Earnings per share for the trailing year BCRX (BioCryst Corp)|VERA: Net earnings per share (EPS TTM)|DNTH - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months PHVS|ABCL: Earnings per share for the trailing year|Net earnings per share (EPS TTM) TRML|Earnings per share for the last twelve months PGEN (Precigen Corp)|Net earnings per share (EPS TTM) PHAR (Pharming Group N.V.)|Net earnings per share for the last four quarters nektar.com (NKTR)|UPB - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Zenas Bio|IMNM (Immunome Corp) - Net earnings per share for the last 12 months|Gossamer Bio Corp. - Earnings per share for the trailing year|KALV (KalVista Pharmaceuticals) - Net earnings per share (EPS TTM)|septerna.com (SEPN) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Pieris Pharmaceuticals, Inc. (PVLA)|Savara Inc - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) RIGL (Rigel Pharmaceuticals Inc)|ANAB - Net earnings per share for the last 12 months|ATXS: Net earnings per share for the last 12 months|Net earnings per share for the last four quarters engene.com ENGN|RAPT: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Aerovate Therapeutics JBIO|Earnings per share for the last twelve months Aclaris|KYTX: Earnings per share for the trailing year|Net earnings per share (EPS TTM) TLSA|Net earnings per share for the last four quarters cabalettabio.com|Earnings per share for the last twelve months Ventyx Biosciences, Inc. VTYX|THTX (Theratechnologies, Inc.) - Earnings per one share for the last 12 months|Avalo Therapeutics Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ELDN (Eledon Pharmaceuticals, Inc)|AGEN: Net earnings per share (EPS TTM)|climbbio.com (CLYM) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Zura Bio Limited|ATYR: Earnings per share for the trailing year|Earnings per share for the last twelve months Adagene (ADAG)|Net earnings per share for the last 12 months ikenaoncology.com IMA|Net earnings per share (EPS TTM) STTK (Shattuck Labs)|Net earnings per share (EPS TTM) Equillium Inc EQ|CNTB: Net earnings per share for the last 12 months|Earnings per share for the trailing year IMUX (Immunic, Inc.)|ATRA: Net earnings per share (EPS TTM)|IFRX - Net earnings per share for the last four quarters|Earnings per share for the last twelve months X4 Pharmaceuticals|Net earnings per share for the last 12 months Adicet (ACET)|Earnings per share for the last twelve months Celularity Inc. (CELU)|Net earnings per share for the last 12 months INmune Bio Inc INMB|Barinthus Bio - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Kezar Life Sciences Inc KZR|SABS - Earnings per share for the last twelve months|AKTX (akaritx.com) - Earnings per share for the last 12 months|ENLV: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Q32 Bio (QTTB)|GOVX (GeoVax Labs Inc) - Net earnings per share (EPS TTM)|EDSA - Net earnings per share for the trailing year|Earnings per share for the last twelve months iBio, Inc. (IBIO)|CARM (carismatx.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) XTLB (XTL Biopharmaceuticals Ltd.)|Net earnings per share for the last four quarters Bolt Biotherapeutics Inc. (BOLT)|HCWB: Net earnings per share for the last 12 months|Earnings per share for the trailing year APVO (Aptevo Therapeutics)|AIM: Net earnings per share (EPS TTM)|ADTX (Aditxt, Inc.) - Earnings per share for the last twelve months|XRTX (XORTX Therapeutics) - Net earnings per share (EPS TTM)|Vyome Holdings Inc. (HIND) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Revelation Bio (REVB)|INDP - Net earnings per one share for the last twelve months|Scinai Immunotherapeutics - Net earnings per share for the last 12 months|Earnings per share for the trailing year CALI|Affimed Therapeutics - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Allakos Inc. ALLK|hookipapharma.com (HOOK) - Earnings per share for the last twelve months|Earnings per share for the last 12 months IGMS|ITOS (iTeos Therapeutics) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months oceanbiomedical.com (OCEA)|Net earnings per share for the last 12 months TCBP (TC BioPharm)|Net earnings per share for the last four quarters Third Harmonic Bio Inc.